Skip Navigation


Japanese Journal of Clinical Oncology Advance Access originally published online on May 8, 2009
Japanese Journal of Clinical Oncology 2009 39(7):460-463; doi:10.1093/jjco/hyp040
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
39/7/460    most recent
hyp040v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nakamura, K.
Right arrow Articles by Boku, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, K.
Right arrow Articles by Boku, N.
Related Collections
Right arrow Clinical Trial Note
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author (2009). Published by Oxford University Press. All rights reserved

Phase II Trial of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin in Patients with Unresectable Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Japan Clinical Oncology Group Study (JCOG0706)

Kenichi Nakamura1, Makoto Tahara2, Naomi Kiyota3, Ryuichi Hayashi4, Tetsuo Akimoto5, Haruhiko Fukuda1, Masato Fujii6 and Narikazu Boku7

1 Clinical Trials and Practice Support Division, Center for Cancer Control and Information Services, National Cancer Center, Tokyo
2 Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Chiba
3 Department of Medical Oncology, Kobe University Hospital, Kobe
4 Department of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Chiba
5 Department of Radiology, Tokyo Women's Medical University Hospital, Tokyo
6 Department of Otolaryngology, National Hospital Organization Tokyo Medical Center
7 Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan

For reprints and all correspondence: Makoto Tahara, Department of Gastrointestinal Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. E-mail: matahara{at}east.ncc.go.jp

Received March 19, 2009; accepted April 1, 2009

A Phase II study was started in Japan to evaluate the efficacy and safety of concurrent chemoradiotherapy with S-1 plus cisplatin in patients with unresectable locally advanced squamous cell carcinoma of the head and neck. This study began in July 2008, and a total of 45 patients will be accrued from 13 institutions within 2 years. The primary endpoint is the clinical complete remission rate. The secondary endpoints are local progression-free survival, overall survival, progression-free survival, time to treatment failure, proportion of patients who achieve nutritional support-free survival and adverse events.

Key Words: head and neck neoplasms • chemoradiotherapy • clinical trials • Phase II


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.